Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| Revenues | 6.0 | 4.2 | 0.0 |
| Revenue growth | 41.6% | | |
| Cost of goods sold | 3.3 | 72.9 | 22.4 |
| Gross profit | 2.7 | -68.6 | -22.4 |
| Gross margin | 45.4% | -1616.1% | |
| Selling, general and administrative | 37.2 | 36.6 | 8.0 |
| Research and development | 13.1 | 9.6 | 5.9 |
| EBIT | -90.9 | -68.6 | -22.4 |
| EBIT margin | -1511.4% | -1616.1% | |
| Pre-tax income | -32.1 | -96.5 | -21.4 |
| Income taxes | 4.6 | -0.2 | 0.1 |
| Tax rate | | 0.2% | |
| Net income | -36.6 | -96.3 | -21.5 |
| Net margin | -609.5% | -2267.6% | |
| |
| Diluted EPS | ($0.44) | ($5.78) | ($1.34) |
| Shares outstanding (diluted) | 83.8 | 16.7 | 16.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|